Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020–2021) in 12 Countries of the C-MOR Consortium
Authors:
- Victoria Virginia BeeksVBVictoria Virginia Beeks
- Souzana AchilleosSouzana Achilleos
- Annalisa QuattrocchiAQAnnalisa Quattrocchi
- Chryso Th. PallariCPChryso Th. Pallari
- Elena CritselisECElena Critselis
- Jose Manuel Rodriguez-LlanesJRJose Manuel Rodriguez-Llanes
- Giuseppe AmbrosioGAGiuseppe Ambrosio
- Andreas ArtemiouAndreas Artemiou
- Catherine Marie BennettCBCatherine Marie Bennett
Open Access
- 22 May 2024
- journal article
- research article
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 14 (2) , 337-348
Abstract
Background: This study investigated cause-specific mortality rates in 12 countries during the COVID-19 pandemic in 2020 and 2021. Methods: We collected weekly cause-specific mortality data from respiratory disease, pneumonia, cardiovascular disease (CVD) and cancer from national vital statistic databases. We calculated excess mortality for respiratory disease (excluding COVID-19 codes), pneumonia, and CVD in 2020 and 2021 by comparing observed weekly against expected mortality based on historical data (2015–2019), accounting for seasonal trends. We used multilevel regression models to investigate the association between country-level pandemic-related variables and cause-specific mortality. Results: Significant reductions in cumulative mortality from respiratory disease and pneumonia were observed in 2020 and/or 2021, except for Georgia, Northern Ireland, Kazakhstan, and Ukraine, which exhibited excess mortality for one or both causes. Australia, Austria, Cyprus, Georgia, and Northern Ireland experienced excess cumulative CVD mortality in 2020 and/or 2021. Australia, Austria, Brazil, Cyprus, Georgia, Northern Ireland, Scotland and Slovenia, experienced increased crude cumulative cancer mortality during 2020 and/or 2021 compared to previous years. Among pandemic-related variables, reported COVID-19 incidence was negatively associated with increased cancer mortality, excess respiratory, (2020) and pneumonia (2021) mortality, and positively associated with respiratory and CVD mortality (2021). Stringency of control measures were negatively associated with excess respiratory disease, CVD, and increased cancer mortality (2021). Conclusions: This study provides evidence of substantial excess mortality from CVD, and notable reductions in respiratory disease and pneumonia in both years across most countries investigated. Our study also highlights the beneficial impact of stringent control measures in mitigating excess mortality from most causes in 2021.Keywords
Funding Information
- University of Nicosia
This publication has 24 references indexed in Scilit:
- Excess mortality by specific causes of deaths in the city of São Paulo, Brazil, during the COVID-19 pandemicPLOS ONE, 2021
- Decrease in hospital admissions for respiratory diseases during the COVID-19 pandemic: a nationwide claims studyThorax, 2021
- Excess deaths in people with cardiovascular diseases during the COVID-19 pandemicEuropean Journal of Preventive Cardiology, 2021
- Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020Eurosurveillance, 2020
- Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital citiesHeart, 2020
- Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020JAMA Internal Medicine, 2020
- Excess Deaths From COVID-19 and Other Causes, March-April 2020JAMA, 2020
- Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, WashingtonJAMA Network Open, 2020
- Distinguishing between direct and indirect consequences of covid-19BMJ, 2020
- The socio-economic implications of the coronavirus pandemic (COVID-19): A reviewInternational Journal of Surgery, 2020